SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VOLTAN, Rebecca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.325
AS - Asia 4.082
EU - Europa 2.935
SA - Sud America 700
Continente sconosciuto - Info sul continente non disponibili 217
AF - Africa 104
OC - Oceania 10
Totale 16.373
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.125
SG - Singapore 1.492
IT - Italia 1.068
CN - Cina 970
BR - Brasile 541
VN - Vietnam 500
DE - Germania 389
HK - Hong Kong 317
PL - Polonia 290
UA - Ucraina 239
GB - Regno Unito 227
TR - Turchia 205
FI - Finlandia 154
BD - Bangladesh 152
FR - Francia 120
SE - Svezia 105
CA - Canada 104
JP - Giappone 104
RU - Federazione Russa 92
IN - India 77
ID - Indonesia 74
NL - Olanda 73
AR - Argentina 63
MX - Messico 55
ZA - Sudafrica 41
ES - Italia 29
IQ - Iraq 28
PK - Pakistan 26
CZ - Repubblica Ceca 24
CO - Colombia 22
EC - Ecuador 21
LT - Lituania 20
BE - Belgio 17
CL - Cile 15
UZ - Uzbekistan 15
EE - Estonia 14
VE - Venezuela 14
TN - Tunisia 13
MY - Malesia 12
AT - Austria 11
CR - Costa Rica 10
IE - Irlanda 10
KR - Corea 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
KE - Kenya 9
RO - Romania 9
SA - Arabia Saudita 9
AU - Australia 8
MA - Marocco 8
PY - Paraguay 8
AZ - Azerbaigian 7
CH - Svizzera 7
JM - Giamaica 7
PH - Filippine 7
TW - Taiwan 7
AL - Albania 6
CY - Cipro 6
IL - Israele 6
IR - Iran 6
JO - Giordania 6
PE - Perù 6
BO - Bolivia 5
EG - Egitto 5
KG - Kirghizistan 5
UY - Uruguay 5
ET - Etiopia 4
LB - Libano 4
NI - Nicaragua 4
NP - Nepal 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
GE - Georgia 3
GR - Grecia 3
HN - Honduras 3
LY - Libia 3
MD - Moldavia 3
NG - Nigeria 3
PT - Portogallo 3
RS - Serbia 3
TZ - Tanzania 3
BB - Barbados 2
DK - Danimarca 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
PS - Palestinian Territory 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AM - Armenia 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BZ - Belize 1
Totale 16.136
Salva come PNG Salva come JPEG
Città #
Ashburn 975
Singapore 931
Fairfield 722
San Jose 619
Woodbridge 604
Houston 407
Beijing 353
Santa Clara 327
Ferrara 314
Hong Kong 309
Chandler 304
Seattle 292
Warsaw 282
Ann Arbor 279
Dallas 273
Council Bluffs 272
Jacksonville 271
Cambridge 268
Wilmington 247
Los Angeles 161
Ho Chi Minh City 156
New York 145
Munich 123
Milan 118
Hanoi 116
Tokyo 95
Izmir 89
Nanjing 82
Boardman 73
Lauterbourg 71
Bologna 68
Princeton 61
Jakarta 58
Helsinki 54
São Paulo 52
Shanghai 50
San Diego 49
Turku 47
Phoenix 43
Rome 43
London 41
Orem 41
Chicago 39
Buffalo 38
Brooklyn 35
Denver 30
Mexico City 30
Poplar 30
Toronto 30
Dong Ket 29
Johannesburg 29
Montreal 28
Da Nang 27
Falls Church 27
Frankfurt am Main 27
The Dalles 27
Boston 26
Bremen 24
Nanchang 23
Istanbul 21
Naples 21
Shenyang 21
Mersin 20
Atlanta 19
Chennai 18
Hebei 18
San Francisco 18
Haiphong 17
Rio de Janeiro 17
Brussels 16
Dearborn 16
Hefei 16
Padua 16
Brno 15
Changsha 15
Manchester 15
Ankara 14
Brasília 14
Tashkent 14
Tianjin 14
Washington 14
Genoa 13
Norwalk 13
Tallinn 13
Amsterdam 12
Florence 12
Kunming 12
Moscow 12
Jiaxing 11
Nuremberg 11
Stockholm 11
Turin 11
Hải Dương 10
New Delhi 10
Ninh Bình 10
Augusta 9
Biên Hòa 9
Guangzhou 9
Mountain View 9
Mumbai 9
Totale 10.959
Salva come PNG Salva come JPEG
Nome #
Netter's Introduzione all'imaging 377
Cell cycle block by p53 acrivation reduces SARS-COV-2 release in infected alveolar basal epithelial A549-hACE2 cells 362
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 349
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 291
Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model 290
Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 286
Expeditious Synthesis and Biological Characterization of Enantio-Enriched (-)-Nutlin-3 285
MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer 281
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 275
Anticancer Activity of Aqueous Extracts from Asparagus officinalis L. Byproduct on Breast Cancer Cells 275
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 263
Antitumoral activity of Asparagus officinalis extracts against breast cancer 260
Actively targeted nanocarriers for drug delivery to cancer cells 260
HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts 259
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 250
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 243
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 243
Multiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imaging 241
Characterization Methods for Nanoparticle–Skin Interactions: An Overview 237
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 234
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 233
Clinical perspectives of TRAIL: Insights into central nervous system disorders 231
Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery 221
Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity 218
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53(wild-type) JVM-2 But Not Towards p53(mutated) BJAB Leukemic Cells 217
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 214
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 213
Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis 204
Heterogeneity of mesenchymal stromal cells in lymphoproliferative disorders 204
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 201
In-vitro anticancer activity of Asparagus officinalis extracts on breast carcinoma 198
SRP-35, a newly identified protein of the skeletal muscle sarcoplasmic reticulum, is a retinol dehydrogenase 187
ACE2 up-regulation by MDM2 inhibition reduces inflammation and monocytes adhesion in HUVEC 187
Enhanced Anti-Melanoma Activity of Nutlin-3a Delivered via Ethosomes: Targeting p53-Mediated Apoptosis in HT144 Cells 182
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 181
In Vitro Skin sensitisation analysis by the U-SENS method for new molecules innovative materials and medical devices 180
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 173
Asparagus officinalis L. aqueous extracts mediate cell cycle block and migration inhibition in breast cancer cells 164
Live recombinant vectors for AIDS vaccine development 164
Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag. 162
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 161
Nutlin-3a-loaded ethosomes as an efficient nanodelivery system target p53 in melanoma 160
Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication 160
The oncogene DEK promotes leukemic cell survival and is downregulated by both nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells 159
Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity 155
p53 and merlin tumor suppressors: Two of a kind 152
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 151
Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents 150
Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples 149
Nutlin-3 Loaded Ethosomes and Transethosomes to Prevent UV-Associated Skin Damage 148
Effects of Nutlin-3a on endothelial cells in the presence of inflammation 145
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib 145
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes 139
Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application 139
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin 138
Cell cycle block by p53 activation reduces SARS-CoV-2 release in A549-hAce2 cells 136
Role of miRNA in adult ocular tumorigenesis 132
MDM2 inhibitors counteract inflammation by stabilization of ACE2 in vitro 132
DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination 132
Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection 130
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 129
Ethosomes nanodelivery of the MDM2 inhibitor Nutlin-3a efficiently induces cells death in melanoma 127
In vitro endothelial cell proliferation assay reveals distinct levels of proangiogenic cytokines characterizing sera of healthy subjects and of patients with heart failure 125
Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. 124
Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo 123
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 123
Dasatinib plus Nutlin-3 shows synergistic anti-leukemic activity in both p53wild-type and p53mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. 122
Nutlin-3 downregulates the expression of the Oncogene TCL1 in primary B Chronic Lymphocytic Leukemic cells. 119
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 115
Nutlin-3a-loaded ethosomes as a delivery system in vitro to Target p53 in melanoma 104
null 103
Anticancer activity of MDM2 inhibition in 2D and bioprinted 3D retinoblastoma cell models 101
null 101
null 100
null 97
Multi-Step Synthesis of Chimeric Nutlin–DCA Compounds Targeting Dual Pathways for Treatment of Cancer 95
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 95
null 94
null 92
Oscillatory turbulent flow in chronic venous disease induces pro-inflammatory and reparative biological signaling 92
Nanoparticles engineered with Rituximab and loaded with Nutlin-3 show promising therapeutic activity in B leukemic xenografts 91
null 90
null 90
null 89
Use of bioactives from agrifood by-products in topical cosmetic hydrogels 89
null 88
MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma 87
null 86
null 86
null 84
null 83
null 81
Induction of humoral and enhanced cellular immune responses by novel core-shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration 79
State of the art of the therapeutic perspective of sorafenib against hematological malignancies 76
null 74
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 70
Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation 66
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3 64
MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies 63
null 55
Totale 16.180
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.379
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.379
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022619 0 0 57 37 89 45 44 28 31 54 71 163
2022/2023767 66 48 32 91 108 98 35 66 99 32 56 36
2023/2024544 57 43 20 15 29 74 21 58 17 16 42 152
2024/20252.332 62 75 174 121 296 201 126 130 380 185 301 281
2025/20266.585 579 383 532 765 857 486 709 357 622 735 354 206
2026/2027822 179 363 280 0 0 0 0 0 0 0 0 0
Totale 16.373